• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » inVentiv Health sells sample management business to J. Knipper

inVentiv Health sells sample management business to J. Knipper

April 8, 2013
CenterWatch Staff

J. Knipper and Company, a provider of healthcare marketing solutions, has acquired the inVentiv Health MySTRO Sample Management and Fulfillment business, including regulatory compliance, sample accountability and fulfillment services.

With the acquisition, J. Knipper becomes the largest end-to-end pharmaceutical samples management service provider in the U.S., dedicated to the pharmaceutical and biotech industry with services spanning all phases of the product lifecycle. These services include marketing, printing, sample and literature distribution, eSampling and direct HCP fulfillment, regulatory compliance, information technology, salesforce productivity and provider data management.

J. Knipper and inVentiv Health will work collaboratively to offer their respective core services and an integrated account management approach to shared customers. The collaboration will allow for J. Knipper to offer sample management and fulfillment services in support of InVentiv Health selling solutions representatives while InVentiv Health will offer tele-detailing services to Knipper multi-channel programs. Terms of the agreement were not disclosed.

"J. Knipper and Company's greater scale in the areas of sample accountability and fulfillment will enhance the services provided to inVentiv Health customers,” said Paul Mignon, president of inVentiv Health Selling Solutions. “And similarly, inVentiv Health's best-in-class tele-detailing capabilities—including our state-of-the-art call center, which is staffed by professional, fully trained and dedicated agents—will provide support and value to J. Knipper and Company's clients. We look forward to continuing to collaborate with the J. Knipper and Company team on delivering customer-focused solutions with real results."

Michael J. Laferrera, president and chief operating officer of J. Knipper, said, "In recognition of the growing need within the pharmaceutical industry to optimize strategies for sample management, I am confident that this acquisition will allow us to enhance our strategic as well as grass roots services by offering an even greater wealth of employee expertise and executional best practices."

Edgemont Capital Partners, a healthcare investment banking firm, acted as exclusive advisor to J. Knipper.

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

  • SurveywBlueBackground-360x240.png

    Mid-Study Updates Delay Trials At Least a Month, CSDD Report Finds

  • Real-TimeData-360x240.png

    Real-Time Data Helped Sponsors Respond to Sites’ Needs During the Pandemic

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing